To hear about similar clinical trials, please enter your email below
Trial Title:
Outcomes of Smoker and Drinker With Esophageal Squamous Cell Carcinoma After Esophagectomy
NCT ID:
NCT06269341
Condition:
Outcomes of Smoker and Drinker After Esophagectomy
Conditions: Official terms:
Carcinoma, Squamous Cell
Esophageal Squamous Cell Carcinoma
Conditions: Keywords:
survival
esophgeal cancer
smoker
drinker
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention
Description:
No intervention
Arm group label:
high-risk
Summary:
Our study demonstrates that patients who did not consume alcohol or smoke had a
significant advantage in overall survival (OS) after undergoing esophagectomy.
Furthermore, our findings indicate that there was no statistically significant difference
in OS between patients with a history of both smoking and drinking, and those who only
smoked or drank
Criteria for eligibility:
Study pop:
patients with esophageal cancer
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
patients with esophageal cancer
Exclusion Criteria:
(1) pathology confirmed a non-squamous cell carcinoma, (2) the tumor was located outside
of the thoracic region, (3) R1/R2 resection was performed indicating incomplete tumor
removal, (4) evidence of distant tumor metastasis was observed, (5) they underwent
preoperative neoadjuvant therapy, (6) pTis/T1a stage (7) Missing data.
Gender:
All
Minimum age:
18 Years
Maximum age:
90 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Sichuan Cancer Hospital and Research Institute
Address:
City:
Chengdu
Zip:
610041
Country:
China
Status:
Recruiting
Contact:
Last name:
Lin Peng, M.D.
Phone:
+8618908190013
Email:
penglinms@126.com
Contact backup:
Last name:
Wenwu He, M.D.
Phone:
+8613350055340
Email:
wenwu_he@126.com
Start date:
February 1, 2010
Completion date:
August 30, 2024
Lead sponsor:
Agency:
Sichuan Cancer Hospital and Research Institute
Agency class:
Other
Source:
Sichuan Cancer Hospital and Research Institute
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06269341
